BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwon OC, Song JJ, Yang Y, Kim SH, Kim JY, Seok MJ, Hwang I, Yu JW, Karmacharya J, Maeng HJ, Kim J, Jho EH, Ko SY, Son H, Chang MY, Lee SH. SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models. EMBO Mol Med 2021;13:e13076. [PMID: 33646633 DOI: 10.15252/emmm.202013076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Alam M, Ali S, Ahmed S, Elasbali AM, Adnan M, Islam A, Hassan MI, Yadav DK. Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases. Int J Mol Sci 2021;22:12162. [PMID: 34830043 DOI: 10.3390/ijms222212162] [Reference Citation Analysis]
2 Couillin I, Riteau N. STING Signaling and Sterile Inflammation. Front Immunol 2021;12:753789. [PMID: 34659260 DOI: 10.3389/fimmu.2021.753789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fu Y, Lorrai I, Zorman B, Mercatelli D, Shankula C, Marquez Gaytan J, Lefebvre C, de Guglielmo G, Kim HR, Sumazin P, Giorgi FM, Repunte-canonigo V, Sanna PP. Escalated (Dependent) Oxycodone Self-Administration Is Associated with Cognitive Impairment and Transcriptional Evidence of Neurodegeneration in Human Immunodeficiency Virus (HIV) Transgenic Rats. Viruses 2022;14:669. [DOI: 10.3390/v14040669] [Reference Citation Analysis]
4 Verma AK, Ahmed SF, Hossain MS, Bhojiya AA, Upadhyay SK, Srivastava AK, Singh N, Harina, Rahaman MM, Bahadur NM. Unlocking SGK1 inhibitor potential of bis-[1-N,7-N, pyrazolo tetraethoxyphthalimido{-4-(3,5-Dimethyl-4-(spiro-3-methylpyazolo)-1,7-dihydro-1H-dipyrazolo[3,4-b;4',3'-e]pyridin-8-yl)}]p-disubstituted phenyl compounds: a computational study. J Biomol Struct Dyn 2021;:1-20. [PMID: 34696688 DOI: 10.1080/07391102.2021.1988711] [Reference Citation Analysis]
5 Barut J, Rafa-Zabłocka K, Jurga AM, Bagińska M, Nalepa I, Parlato R, Kreiner G. Genetic lesions of the noradrenergic system trigger induction of oxidative stress and inflammation in the ventral midbrain. Neurochem Int 2022;:105302. [PMID: 35150790 DOI: 10.1016/j.neuint.2022.105302] [Reference Citation Analysis]
6 Lai TT, Kim YJ, Ma H, Kim YE. Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy. JMD 2022;15:1-14. [DOI: 10.14802/jmd.21078] [Reference Citation Analysis]
7 Ravichandran KA, Heneka MT. Inflammasome activation in neurodegenerative diseases. Essays Biochem 2021;65:885-904. [PMID: 34846519 DOI: 10.1042/EBC20210021] [Reference Citation Analysis]
8 Miller SJ, Campbell CE, Jimenez-corea HA, Wu G, Logan R. Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease. Front Neurosci 2022;16:824191. [DOI: 10.3389/fnins.2022.824191] [Reference Citation Analysis]
9 Noor S, Mohammad T, Ashraf GM, Farhat J, Bilgrami AL, Eapen MS, Sohal SS, Yadav DK, Hassan MI. Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review. Int J Biol Macromol 2021;193:562-73. [PMID: 34715204 DOI: 10.1016/j.ijbiomac.2021.10.165] [Reference Citation Analysis]